February 11, 2012
Cheshire drug maker Alexion Pharmaceuticals Inc. has appointed Andreas Rummelt to its board of directors.
Rummelt was a member of the executive committee of Novartis from 2006 to 2010, where he most recently served as group head of quality assurance and technical operations. (AP)
This article does not currently have any comments